Wednesday begins at 8:00 am with the Robert L. Brent Lecture: Teratogen Update entitled Teratology and Public Health: Working Together to Make Recommendations for Pregnant Women in the Face of Uncertainty, which will feature lecturer Sonja A. Rasmussen.
The Wiley-Blackwell Symposium: From Fleas to Fish and Beyond: Advances in Alternative Assays to Predict Developmental Toxicity will be presented at 8:30 am. This session will explore the state of the science regarding in vitro developmental toxicity methods playing a role in more efficient testing strategies. Use of these models to examination relationships between molecular initiating events and their biological consequences, and for the effects of chemical exposures to interacting stressors (e.g. chemical and nutrition) will be discussed. The session aims to provide information on data interpretation, sensitivity and precision, and the translatability of the respective assay data to humans.
The Public Affairs Committee Symposium entitled Thrombosis during Pregnancy: Risks, Prevention and Treatment for Mother and Fetus will be presented at 1:30 pm. Pregnant women are at an increased risk for thrombotic events including deep venous thrombosis (DVT), pulmonary embolism (PE), cerebral vein thrombosis, myocardial infarction, and stroke. The symposium will discuss the factors contributing to the increased risk for thrombosis during pregnancy and new approaches for selection of therapies. Speakers include a medical team leader from US FDA and academic experts in cutting-edge clinical research from international research centers.
Platform Session 5 entitled In Vitro, Stem Cells, and Alternative Approaches will be held concurrently at 1:30 pm and will feature ten presentations.
For more details about the Annual Meeting, visit the meeting website. Information about daily activities can be viewed via the Annual Meeting Blog.